Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPE: Peginterferon alfa-2a + NA in HBeAg+ CHB
NCT02474316Phase 4Unknown
- Sponsor
- Ruijin Hospital
- Start
- Aug 2014
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02474316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474316.